Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-61.

Shekelle PG, Morton SC, Maglione M, et al. Pharmacological and Surgical Treatment of Obesity. Summary, Evidence Report/Technology Assessment: Number 103. AHRQ Publication Number 04-E028-1, July 2004. Agency for Healthcare Research and Quality, Rockville, MD. Available online at http://www.ahrq.gov/clinic/epcsums/obesphsum.htm.

Anderson JW, Konz EC, Frederics RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74(5):579-84.

Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. October 13, 2004; 292(14):1724-1728.

Consensus development conference panel. NIH conference: Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956-961.

Cottam DR, Atkinson J, Anderson A, Grace B, Fisher B. A case-controlled matched-pair cohort study of laparoscopic Roux-en-Y gastric bypass and Lab-Band atients in a single U.S. center with three-year followup. Obes Surg. 2006;16(5):534-40

Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for Type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323.

Geiss LS, Pan L, Cadwell B, et al. Changes in incidence of diabetes in U.S. adults, 1997-2003. Am J Prev Med. 2006;30(5):371-377.

Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from Type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55:2025-2031.

Harris MI. Impaired glucose tolerance in the U.S. population. Diabetes Care. 1989;12:464-74.

Kim TH, Daud AO, DiGiorgi M, et al. Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc. 2006;20:202-209.

Klein S, Sheard NF, Pi-Sunyer X, et al. Weight management through lifestyle modification for the prevention and management of Type 2 diabetes: rationale and strategies. Statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Diabetes Care. 2004;27(8):2067-2073.

Knowler WC, Barret-Connor E, Fowler SE, et al. Reduction in the incidence of Type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.

Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormones and leptin levels. Obesity. 2006;14(9):1553-1561.

Lee M, Aronne LJ. Weight management for Type 2 diabetes mellitus: global cardiovascular risk reduction. Am J Cardiol. 2007; 99[suppl]:68B-79B.

McGuire MT, Wing RR, Hill JO. The prevalence of weight loss maintenance among American adults. Int J Obes Relat Metab Disord. 1999;23(12):1314-9.

Norris SL, Zhang X, Avenell A, Gregg E, Brown TJ, Schmid CH, Lau J. Long-term non-pharmacological weight loss interventions for adults with Type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD004095. DOI: 10.1002/14651858.CD004095.pub2.

Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Pharmacotherapy for weight loss in adults with Type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2005, Issue 1. Art. No.: CD004096. DOI: 10.1002/14651858.CD004096.pub2.

Parikh MS, Laker S, Weiner M, Hajiseyedjavadi O, Ren CJ. Objective comparison of complications resulting from laparoscopic bariatric procedures. J Am Coll Surg. 2006;202(2):252-261.

Perry IJ, Wannamethee SG, Walker MK, et al. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ. 1995;310(6979):545-6.

Pories WJ, Albrecht RJ. Etiology of Type II diabetes mellitus: role of the foregut. World J Surg. 2001;25(4):527-31.

Schernthaner G, Morton JM. Bariatric surgery in patients with morbid obesity and Type 2 diabetes. Diabetes Care. 2008;31:S297-302.

Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93.

Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-52.

Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005;142(7):525-531.

Stafford RS, Farhat JH, Misra B, Schoenfeld DA. National patterns of physician activities related to obesity management. Arch Fam Med. July 2000; 9(7):631-638.

Svetkey LP, Stevens VJ, Brantley PJ, et al. Comparison of strategies for sustaining weight loss. JAMA. 2008;299(10):1139-48.

The Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with Type 2 diabetes: one year results of the Look AHEAD trial. Diabetes Care. 2007;30(6):1374-1383.

Wadden TA, Berkowitz RI, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353(20):2111-20.

Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology. 2007;132(6):2007.

Weiss EC, Galuska DA, Kettel Khan L, Gillespie C, Serdula MK. Weight regain in U.S. adults who experienced substantial weight loss, 1999-2002. Am J Prev Med. 2007 Jul;33(1):34-40.

Williams KV, Kelley DE. Metabolic consequences of weight loss on glucose metabolism and insulin action in Type 2 diabetes. Diabetes Obes Metab. 2000;2:121-9.

Wing RR, Blair EH, Bononi P, et al. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care. 1994;17(1):30-6.